Skip to content
10-Q

Quarterly Report

Puramed Bioscience Inc.

0001354488-14-005921

← back to feed
Filed
Nov 19, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · Nov 17, 2014 199.82M sh
Capex Q1 2015 · Sep 30, 2014 $0
Capex Q1 2015 · Sep 30, 2013 $232
Operating Cash Flow Q1 2015 · Sep 30, 2014 −$43.42K
Operating Cash Flow Q1 2015 · Sep 30, 2013 −$130.23K
Short Term Debt Q1 2015 · Sep 30, 2014 $532.72K
Short Term Debt Q1 2015 · Jun 30, 2014 $320.57K
Stockholders Equity Q1 2015 · Sep 30, 2014 −$5.52M
Stockholders Equity Q1 2015 · Jun 30, 2014 −$5.14M
Current Liabilities Q1 2015 · Sep 30, 2014 $5.67M
Current Liabilities Q1 2015 · Jun 30, 2014 $5.32M
Current Assets Q1 2015 · Sep 30, 2014 $37.19K
Current Assets Q1 2015 · Jun 30, 2014 $71.08K
Total Assets Q1 2015 · Sep 30, 2014 $150.68K
Total Assets Q1 2015 · Jun 30, 2014 $186.34K
Sga Expense Q1 2015 · Sep 30, 2014 $23.77K
Sga Expense Q1 2015 · Sep 30, 2013 $43.23K
Net Income Q1 2015 · Sep 30, 2014 −$822.65K
Net Income Q1 2015 · Sep 30, 2013 −$702.72K
Operating Income Q1 2015 · Sep 30, 2014 −$135.44K
Operating Income Q1 2015 · Sep 30, 2013 −$283.55K
Gross Profit Q1 2015 · Sep 30, 2014 −$1.3K
Gross Profit Q1 2015 · Sep 30, 2013 −$26.6K
Cost Of Revenue Q1 2015 · Sep 30, 2014 $4.93K
Cost Of Revenue Q1 2015 · Sep 30, 2013 $26.6K
Revenue Q1 2015 · Sep 30, 2014 $3.64K
Revenue Q1 2015 · Sep 30, 2013 $0